Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

3D-printing of devices will overtake drugs

This article was originally published in Clinica

Executive Summary

As the cost of 3D printing comes down and becomes more competitively priced with existing manufacturing technologies, 3D-printed medical devices and prosthetics will become more common over the next 10 years. On the other hand, 3D-printed drugs will find it more challenging to overcome cost hurdles, thus making it more unlikely for drugs to be manufactured widely using this technology.